Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Scientists in China have identified specific physical behaviours that could provide early warning signs for Parkinson's ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Video. A unique programme in Rio de Janeiro is helping people with Parkinson’s disease manage their symptoms through the art of capoeira.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

A study links living near golf courses to higher Parkinson's risk, with strongest association found in those one to three ...

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...

针对帕金森病（PD）患者跌倒风险与认知障碍共病难题，研究者开展TAK-071（M1受体正向变构调节剂）的II期随机对照试验。结果显示该药物虽未改善步态变异（p=0.6），但显著提升认知评分，安全性良好（胃肠道不良反应率=7.4%）。为胆碱能靶向治疗PD非运动症状提供新证据。